Impax Laboratories, Inc. (NASDAQ: IPXL), today announced a Settlement Agreement to resolve a contract dispute relating to an agreement entered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Hot Corp. News Hot FDA News Management Comments

Impax Laboratories (IPXL) PT Raised to $20 at Cowen Following Strong 2Q August 9, 2017 1:54 PM Impax Announces Settlement of Contract Litigation on Opana® ER (Oxymorphone Hydrochloride) CII Extended-Release TabletsAugust 7, 2017 7:30 AM Teva Pharma (TEVA) PT Lowered to $27 at Cantor FitzgeraldAugust 3, 2017 12:51 PM